Stay updated on HexaBody-DR5/DR5 Safety Clinical Trial
Sign up to get notified when there's something new on the HexaBody-DR5/DR5 Safety Clinical Trial page.

Latest updates to the HexaBody-DR5/DR5 Safety Clinical Trial page
- Check6 days agoChange DetectedGastric cancer was added to the study's conditions. The page revision notes show an update to v3.4.2 and the removal of the prior funding-status notice (v3.4.1).SummaryDifference0.4%

- Check13 days agoChange DetectedAdded a government funding lapse notice and NIH Clinical Center status information (cc.nih.gov and opm.gov), and updated the page revision to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedGlossary functionality is now visible on the page, enabling quick access to defined terms. The footer and labeling have been updated to reflect the latest QC status and compliance notes, including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision tag 'v3.4.0'.SummaryDifference0.2%

- Check34 days agoChange DetectedRevision: v3.3.4 updated. The Study Details page content and layout appear unchanged.SummaryDifference0.1%

- Check55 days agoChange DetectedLocations section updated to include Connecticut and Texas sites and the revision tag updated to v3.3.3. The v3.3.2 listing and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.3%

- Check84 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the site.SummaryDifference0.1%

Stay in the know with updates to HexaBody-DR5/DR5 Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HexaBody-DR5/DR5 Safety Clinical Trial page.